Current and emergent treatments for symptoms and neurocognitive impairment in schizophrenia.
about
The current conceptualization of negative symptoms in schizophreniaModulating NMDA Receptor Function with D-Amino Acid Oxidase Inhibitors: Understanding Functional Activity in PCP-Treated Mouse Model.Cariprazine for the Treatment of Bipolar Disorder.Time to Re-focus onto Cognitive Symptoms in Schizophrenia.Septal Cholinergic Neuromodulation Tunes the Astrocyte-Dependent Gating of Hippocampal NMDA Receptors to Wakefulness.Rodent Mismatch Negativity/theta Neuro-Oscillatory Response as a Translational Neurophysiological Biomarker for N-Methyl-D-Aspartate Receptor-Based New Treatment Development in Schizophrenia.
P2860
Current and emergent treatments for symptoms and neurocognitive impairment in schizophrenia.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Current and emergent treatment ...... e impairment in schizophrenia.
@ast
Current and emergent treatment ...... e impairment in schizophrenia.
@en
type
label
Current and emergent treatment ...... e impairment in schizophrenia.
@ast
Current and emergent treatment ...... e impairment in schizophrenia.
@en
prefLabel
Current and emergent treatment ...... e impairment in schizophrenia.
@ast
Current and emergent treatment ...... e impairment in schizophrenia.
@en
P2860
P1476
Current and emergent treatment ...... e impairment in schizophrenia.
@en
P2860
P2888
P304
P356
10.1007/S40501-014-0010-9
P577
2015-06-01T00:00:00Z
P5875
P6179
1043503564